CLINICAL_TRIALS trial_result · 2013-05-24

Clinical Trial Update: Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease [Phase 1]

Phase 1 safety and tolerability study of CTP-499 in adults with Stage 3 chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Concert Pharmaceuticals | Conditions: Stage 3 Chronic Kidney Disease | Phase 1 | Status: COMPLETED